Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will share 11 new research studies highlighting advancements in oncology and ...

Despite a 4% revenue drop, Myriad Genetics Inc (MYGN) focuses on operational efficiencies and strategic product launches to ...

Highlights Third quarter 2025 revenue of $205.7 million decreased by 4% year-over-year but was flat when excluding previously discussed headwinds1 of $8.1 million, consistent with management ...

Myriad Genetics (($MYGN)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call for Myriad Genetics ...

Letter writers discuss the proposed reproductive health constitutional amendment, the governor’s race and the attorney ...

And can conservative feminism fix it?

With early career and workforce model changes, successful companies need a new approach to training the pipeline.

Advertisement Article continues below this ad Here's what to know about the science of pregnancy and extreme heat: Pregnancy changes the body in myriad ways ... environmental coverage receives ...

Despite decades of efforts to improve school attendance and truancy, a KXAN investigation found Texas doesn’t track student ...

Genetic testing company Myriad Genetics (NASDAQ:MYGN) in Q3 CY2025, but sales fell by 3.6% year on year to $205.7 million.

Netflix’s Death by Lightning retells James Garfield’s assassination. See the eight U.S. presidents who never finished their ...

Among a myriad of problems affecting women in sport, the vast majority of football boots are designed with men’s feet in mind ...